Elsevier

The Lancet

Volume 377, Issue 9764, 5–11 February 2011, Pages 450-451
The Lancet

Comment
Rethinking health-care systems: a focus on chronicity

https://doi.org/10.1016/S0140-6736(10)61856-9Get rights and content

References (10)

There are more references available in the full text version of this article.

Cited by (82)

  • How do social and economic vulnerabilities shape the work of participating in care? Everyday experiences of people living with kidney failure in Argentina

    2022, Social Science and Medicine
    Citation Excerpt :

    These changes, the rising costs of care and the medicalization of phenomena not previously dealt with by medicine, made healthcare a political and economic problem that shifted care to patients and restructured medical care (Conrad, 2007). The emerging burden of chronic disease fell upon a medical profession born in an era of acute disease predominance, and while health systems are confronted with a chronic disease pandemic, the strategies designed to manage chronic conditions often overburden patients and their families; when this happens, treatment could be interrupted, comorbidities may occur, quality of life is likely to be reduced, and survival can diminish (Allotey et al., 2011). These patients are encouraged to monitor and manage their health, gain knowledge about the disease and assume more responsibilities related to their health (Clarke et al., 2003).

  • Management of diabetic ketoacidosis in special populations

    2021, Diabetes Research and Clinical Practice
    Citation Excerpt :

    DKA remains the commonest cause for hospital admissions in patients with type 1 and type 2 diabetes in several developing countries, with rates ranging from 36 to 80% [61–63] and is associated with unacceptably high mortality rates of 10–30% in many developing countries [64–68]. A lack of economic resources is a key factor with the cost of managing diabetes in some African countries being one and a half times higher than the annual income per person and 50 times higher than the government health expenditure per person [69]. The availability of insulin also continues to be a challenge and the cost of insulin can form up to 10% of the total national healthcare budget for some countries [70].

View all citing articles on Scopus
View full text